HOLIBACT is a prescription combination medicine commonly used in the treatment of Helicobacter pylori (H. pylori) infection. H. pylori is a type of bacteria associated with stomach and duodenal ulcers, gastritis, and certain digestive discomforts. HOLIBACT contains a combination of antibiotics and a proton pump inhibitor (PPI) to help eliminate the bacteria while reducing stomach acid, which promotes healing of the stomach lining and enhances antibiotic effectiveness. It is typically used as part of a short-term eradication regimen as directed by a healthcare professional.

Active Ingredient(s) / Generic Name
HOLIBACT commonly contains a combination of the following active ingredients (may vary slightly by manufacturer):
• Amoxicillin (a penicillin-class antibiotic)
• Clarithromycin (a macrolide antibiotic)
• Omeprazole (a proton pump inhibitor that reduces stomach acid)

Strengths may vary depending on the specific pack configuration.

Brand name/manufacture/marketer
Brand Name: HOLIBACT
Manufactured/Marketed by: Varies by country and supplier. Refer to the product packaging for specific manufacturer details.

Indications / Uses
HOLIBACT is indicated for:
• Eradication of Helicobacter pylori infection
• Treatment of duodenal ulcers associated with H. pylori
• Treatment of gastric ulcers associated with H. pylori
• Reduction of ulcer recurrence when H. pylori infection is present

It is usually taken for a fixed duration as prescribed, often in a combination therapy pack to ensure proper dosing of all components.

Storage Instructions
Store below 25°C in a cool, dry place.
Protect from moisture and direct sunlight.
Keep out of reach of children.
Do not use after the expiry date stated on the packaging.

Disclaimer
This medication is available by prescription only. Always use HOLIBACT exactly as prescribed by a qualified healthcare professional. Do not stop treatment early, even if symptoms improve. Consult your doctor or pharmacist for proper diagnosis, dosing instructions, and information about possible side effects or drug interactions.